Figures & data
Figure 1. ISG15 and HERC5 levels were increased and β-catenin levels were decreased in the liver tissue of the EtOH-Fed Mice. (A) Establishment of an alcoholic fatty liver model. Hematoxylin and eosin (H&E) staining and Oil Red staining of alcoholic fatty liver mice liver sections (50×, 200×), Data represent the mean ± SD for 6–8 mice. (B-C) The expression levels of SREBP-1 and PPAR-α were detected by qRT-PCR and western blotting. (D-F) The mRNA expression levels of ISG15, HERC5, and β-Catenin were detected by qRT-PCR. (G) Results of the triglyceride (TG) levels of the hepatic tissue. (H-J) The protein expression levels of ISG15, HERC5, and β-catenin were detected by qRT-PCR and western blotting. *p < 0.05, **p < 0.01 versus control group. Data represent the mean ± SD for 3–4 independent experiments.
![Figure 1. ISG15 and HERC5 levels were increased and β-catenin levels were decreased in the liver tissue of the EtOH-Fed Mice. (A) Establishment of an alcoholic fatty liver model. Hematoxylin and eosin (H&E) staining and Oil Red staining of alcoholic fatty liver mice liver sections (50×, 200×), Data represent the mean ± SD for 6–8 mice. (B-C) The expression levels of SREBP-1 and PPAR-α were detected by qRT-PCR and western blotting. (D-F) The mRNA expression levels of ISG15, HERC5, and β-Catenin were detected by qRT-PCR. (G) Results of the triglyceride (TG) levels of the hepatic tissue. (H-J) The protein expression levels of ISG15, HERC5, and β-catenin were detected by qRT-PCR and western blotting. *p < 0.05, **p < 0.01 versus control group. Data represent the mean ± SD for 3–4 independent experiments.](/cms/asset/6f021031-a878-4350-8c85-c1b33f670338/yrer_a_2109360_f0001_oc.jpg)
Figure 2. The model of EtOH-stimulated AML-12 cells wherein ISG15, and HERC5 had high expression levels and β-catenin had low expression levels. (A-B) The expression levels of ISG15 and HERC5 were detected by qRT-PCR. (C-E) The expression levels of ISG15 and HERC5 were detected by western blotting. (F-G) The expression levels of β-Catenin were detected by qRT-PCR and western blotting. (H) The expression levels of SREBP-1 and PPAR-α were detected by qRT-PCR. (I) The expression levels of SREBP-1, PPAR-α were detected by western blotting. (J) The expression of TG levels in cell supernatants. *p < 0.05, **p < 0.01 versus control group. Data represent the mean ± SD for 3–4 independent experiments.
![Figure 2. The model of EtOH-stimulated AML-12 cells wherein ISG15, and HERC5 had high expression levels and β-catenin had low expression levels. (A-B) The expression levels of ISG15 and HERC5 were detected by qRT-PCR. (C-E) The expression levels of ISG15 and HERC5 were detected by western blotting. (F-G) The expression levels of β-Catenin were detected by qRT-PCR and western blotting. (H) The expression levels of SREBP-1 and PPAR-α were detected by qRT-PCR. (I) The expression levels of SREBP-1, PPAR-α were detected by western blotting. (J) The expression of TG levels in cell supernatants. *p < 0.05, **p < 0.01 versus control group. Data represent the mean ± SD for 3–4 independent experiments.](/cms/asset/67d63da2-8bf4-4d40-85e2-f1b48f40555e/yrer_a_2109360_f0002_ob.jpg)
Figure 3. ISG15 and HERC5 levels were increased and β-catenin levels were decreased in EtOH-stimulated L02 cells. (A-B) The expression levels of ISG15 and HERC5 were detected by qRT-PCR. (C-E) The expression levels of ISG15 and HERC5 were detected by western blotting. (F-G) The expression levels of β-Catenin were detected by qRT-PCR and western blotting. (H) The expression levels of SREBP-1 and PPAR-α were detected by qRT-PCR. (I) The expression levels of SREBP-1 and PPAR-α were detected by western blotting. (J) The expression of TG levels in cell supernatants. *p < 0.05, **p < 0.01 versus control group. Data represent the mean ± SD for 3–4 independent experiments.
![Figure 3. ISG15 and HERC5 levels were increased and β-catenin levels were decreased in EtOH-stimulated L02 cells. (A-B) The expression levels of ISG15 and HERC5 were detected by qRT-PCR. (C-E) The expression levels of ISG15 and HERC5 were detected by western blotting. (F-G) The expression levels of β-Catenin were detected by qRT-PCR and western blotting. (H) The expression levels of SREBP-1 and PPAR-α were detected by qRT-PCR. (I) The expression levels of SREBP-1 and PPAR-α were detected by western blotting. (J) The expression of TG levels in cell supernatants. *p < 0.05, **p < 0.01 versus control group. Data represent the mean ± SD for 3–4 independent experiments.](/cms/asset/cbe9d521-286b-4f67-a8e0-0e0336f3ebae/yrer_a_2109360_f0003_ob.jpg)
Figure 5. HERC5-siRNA downregulated the levels of β-catenin in EtOH-stimulated L02 cells. (A) Result of the qRT-PCR analysis of HERC5 mRNA expression. (B-C) Results of western blotting analysis of HERC5 and β-Catenin. (D-E) HERC5-siRNA alleviated lipid metabolism disorders in EtOH-stimulated L02 cells. Results of the qRT-PCR and western blotting analysis of SREBP-1and PPAR-α. (F) The expression of TG levels in cell supernatants. (G) The apoptosis protein expression of FOXO3a, BIM, Cleaved-Caspase-3, Bax and Bcl-2 were analyzed by western blotting. (H) The levels of apoptosis were analyzed by flow cytometry. *p < 0.05, **p < 0.01 versus control group. #p < 0.05 or ##p < 0.01 versus NC group. Data represent the mean ± SD for 3–4 independent experiments.
![Figure 5. HERC5-siRNA downregulated the levels of β-catenin in EtOH-stimulated L02 cells. (A) Result of the qRT-PCR analysis of HERC5 mRNA expression. (B-C) Results of western blotting analysis of HERC5 and β-Catenin. (D-E) HERC5-siRNA alleviated lipid metabolism disorders in EtOH-stimulated L02 cells. Results of the qRT-PCR and western blotting analysis of SREBP-1and PPAR-α. (F) The expression of TG levels in cell supernatants. (G) The apoptosis protein expression of FOXO3a, BIM, Cleaved-Caspase-3, Bax and Bcl-2 were analyzed by western blotting. (H) The levels of apoptosis were analyzed by flow cytometry. *p < 0.05, **p < 0.01 versus control group. #p < 0.05 or ##p < 0.01 versus NC group. Data represent the mean ± SD for 3–4 independent experiments.](/cms/asset/c88601ad-8b6f-4ed2-96ad-92556bdc0958/yrer_a_2109360_f0005_oc.jpg)
Figure 6. Overexpressed HERC5 upregulated the levels of β-catenin ISGylation in EtOH-stimulated L02 cells. (A) Results of the qRT-PCR analysis of HERC5 mRNA expression. (B-C) Results of the western blotting analyses of HERC5 and β-Catenin. (D-E) Overexpressed HERC5 aggravated lipid metabolism disorders in EtOH-stimulated L02 cells. Results of the qRT-PCR and western blotting analyses of SREBP-1 and PPAR-α. (F) The expression of TG levels in cell supernatants. (G) The apoptosis protein expression of FOXO3a, BIM, Cleaved-Caspase-3, Bax and Bcl-2 were analyzed by western blotting. (H) The levels of apoptosis were analyzed by flow cytometry. *p < 0.05, **p < 0.01 versus control group. #p < 0.05 or ##p < 0.01 versus Vector group. Data represent the mean ± SD for 3–4 independent experiments.
![Figure 6. Overexpressed HERC5 upregulated the levels of β-catenin ISGylation in EtOH-stimulated L02 cells. (A) Results of the qRT-PCR analysis of HERC5 mRNA expression. (B-C) Results of the western blotting analyses of HERC5 and β-Catenin. (D-E) Overexpressed HERC5 aggravated lipid metabolism disorders in EtOH-stimulated L02 cells. Results of the qRT-PCR and western blotting analyses of SREBP-1 and PPAR-α. (F) The expression of TG levels in cell supernatants. (G) The apoptosis protein expression of FOXO3a, BIM, Cleaved-Caspase-3, Bax and Bcl-2 were analyzed by western blotting. (H) The levels of apoptosis were analyzed by flow cytometry. *p < 0.05, **p < 0.01 versus control group. #p < 0.05 or ##p < 0.01 versus Vector group. Data represent the mean ± SD for 3–4 independent experiments.](/cms/asset/60ce6c33-3482-4a4c-be32-5d5676a80c79/yrer_a_2109360_f0006_oc.jpg)
Figure 7. The ISGylation of β-catenin can regulate cell lipid metabolism by altering ROS levels. (A-C) Results of ROS levels in L-02 cells with HERC5-siRNA and pEGFP-HERC5 transfection. (D) Results of the ROS levels in L-02 cells with addition of NAC. (E) Results of the western blotting analysis of SREBP-1 and PPAR-α. (F) Results of the TG analysis. β-catenin ISGylation affects cell apoptosis by regulating ROS levels. (G) The levels of apoptosis were detected by flow cytometry. *p < 0.05, **p < 0.01 versus control group. #p < 0.05, ##p < 0.01 versus NC/Vector group. &p < 0.05, &&p < 0.01 versus pEGFP-HERC5. Data represent the mean ± SD for 3–4 independent experiments.
![Figure 7. The ISGylation of β-catenin can regulate cell lipid metabolism by altering ROS levels. (A-C) Results of ROS levels in L-02 cells with HERC5-siRNA and pEGFP-HERC5 transfection. (D) Results of the ROS levels in L-02 cells with addition of NAC. (E) Results of the western blotting analysis of SREBP-1 and PPAR-α. (F) Results of the TG analysis. β-catenin ISGylation affects cell apoptosis by regulating ROS levels. (G) The levels of apoptosis were detected by flow cytometry. *p < 0.05, **p < 0.01 versus control group. #p < 0.05, ##p < 0.01 versus NC/Vector group. &p < 0.05, &&p < 0.01 versus pEGFP-HERC5. Data represent the mean ± SD for 3–4 independent experiments.](/cms/asset/f4322d20-26f9-4c74-aab8-14e9d37e3870/yrer_a_2109360_f0007_oc.jpg)
Data availability statement
The authors confirm that the datasets used and analyzed during the current study are available from the corresponding author on reasonable request.